1 hour ago
HomeMarket NewsAlkem Labs shares in focus as sellers look to offload 1.5% stake via block deal
The term sheet also specifies a 90-day lock-up period on any further sale of shares by the sellers.
1 Min Read
Shares of Alkem Laboratories Ltd. are expected to be in focus on Tuesday, June 2, after a block deal was launched in the company's stock, according to sources and a term sheet accessed by CNBC-TV18.
The transaction involves the sale of up to a 1.5% stake in Alkem Laboratories by the Samprada and Nanhamati Family Trust, represented by authorised individual beneficiary and seller Sandeep Singh, along with authorised individual beneficiary and seller Jayanti Sinha.
The deal is estimated to be worth between ₹936 crore and ₹956 crore.
The floor price has been set at ₹5,200 per share, representing a discount of about 2.2% to Monday's closing price of ₹5,314.50 per share.
The term sheet also specifies a 90-day lock-up period on any further sale of shares by the sellers.
Shares of Alkem Laboratories settled 3.27% lower at ₹5,318 on Monday. The stock has declined around 3% so far in 2026.
